文献速递皮肤肿瘤

STK11通过抑制信号转导与转录激活因子3/5及FAK阻止皮肤黑色素瘤侵袭

STK11 Prevents Invasion through Signal Transducer and Activator of Transcription 3/5 and FAK Repression in Cutaneous Melanoma.
PubMed 文献 · J Invest Dermatol · 2021-10-30

在两种人BRAF突变黑色素瘤细胞系中用CRISPR/Cas9敲除STK11,发现STK11缺失降低对BRAF抑制剂的敏感性,并在三维球体和斑马鱼异种移植模型中增加侵袭表型;STK11过表达可逆转侵袭表型,NRAS突变细胞系敲除STK11也增加侵袭。STK11在原发性黑色素瘤中表达,在转移灶尤其是脑转移中显著降低;敲除细胞中STAT3/5和FAK活化磷酸化增加,用其抑制剂可逆转BRAF和NRAS突变细胞的侵袭表型。

要点

  • STK11缺失降低BRAF突变黑色素瘤细胞对BRAF抑制剂的敏感性。
  • STK11缺失在三维球体和斑马鱼异种移植模型中增加侵袭表型。
  • STAT3/5和FAK抑制剂可逆转BRAF及NRAS突变细胞的侵袭表型。

核心结论

  • STK11失活导致BRAF和NRAS突变皮肤黑色素瘤出现侵袭表型增加,该表型可被STAT3/5和FAK抑制靶向。

研究设计与样本

  • 在两种人BRAF突变黑色素瘤细胞系中用CRISPR/Cas9敲除STK11,并在NRAS突变黑色素瘤细胞系中敲除STK11。
  • 使用三维球体和体内斑马鱼异种移植模型评估侵袭表型。
  • 检测STK11在原发性人黑色素瘤肿瘤和黑色素瘤转移灶中的表达。

主要发现

  • STK11敲除降低两种BRAF突变细胞系对BRAF抑制剂的敏感性。
  • STK11缺失在两种BRAF突变细胞系的三维球体和斑马鱼异种移植模型中增加侵袭表型,STK11过表达可逆转该侵袭表型。
  • STK11敲除在NRAS突变黑色素瘤细胞系中也增加侵袭。
  • STK11在原发性人黑色素瘤肿瘤中表达,但在黑色素瘤转移灶尤其是脑转移中表达显著降低。
  • STK11敲除细胞中STAT3/5和FAK的活化磷酸化增加,用STAT3/5和FAK抑制剂可逆转BRAF和NRAS突变细胞的侵袭表型。

关键数值与推荐

  • STK11突变发生于5‒10%的皮肤黑色素瘤。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The STK11/LKB1 is a tumor suppressor involved in metabolism and cell motility. In BRAFV600E melanoma, STK11 is inactivated by extracellular signal‒regulated kinase and RSK, preventing it from binding and activating adenosine monophosphate-activated protein kinase and promoting melanoma cell proliferation. Although STK11 mutations occur in 5‒10% of cutaneous melanoma, few functional studies have been performed. By knocking out STK11 with CRISPR/Cas9 in two human BRAF-mutant melanoma cell lines, we found that STK11 loss reduced the sensitivity to a BRAF inhibitor. More strikingly, STK11 loss led to an increased invasive phenotype in both three-dimensional spheroids and in vivo zebrafish xenograft models. STK11 overexpression consistently reversed the invasive phenotype. Interestingly, STK11 knockout increased invasion also in an NRAS-mutant melanoma cell line. Furthermore, although STK11 was expressed in primary human melanoma tumors, its expression significantly decreased in melanoma metastases, especially in brain metastases. In the STK11-knockout cells, we observed increased activating phosphorylation of signal transducer and activator of transcription 3/5 and FAK. Using inhibitors of signal transducer and activator of transcription 3/5 and FAK, we reversed the invasive phenotype in both BRAF- and NRAS-mutated cells. Our findings confirm an increased invasive phenotype on STK11 inactivation in BRAF- and NRAS-mutant cutaneous melanoma that can be targeted by signal transducer and activator of transcription 3/5 and FAK inhibition.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Dzung A, Saltari A, Tiso N, et al. STK11 Prevents Invasion through Signal Transducer and Activator of Transcription 3/5 and FAK Repression in Cutaneous Melanoma. J Invest Dermatol. 2021. PMID: 34757069. doi:10.1016/j.jid.2021.09.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。